D
PharmaCyte Biotech, Inc. PMCB
$1.04 $0.032.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Net Income -104.18% 9,083.97% 1,877.84% 1,866.55% 552.43%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 87.33% -1,156.80% -2,145.37% -4,593.89% -898.83%
Change in Net Operating Assets 233.87% 353.95% 323.97% 84.85% -75.26%
Cash from Operations -60.37% -38.43% -7.78% 21.58% -21.19%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 100.00% -40.00% -40.00% -- --
Cash from Investing 100.00% -40.00% -40.00% -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -100.00% -100.00% -100.00%
Repurchase of Common Stock 27.49% 90.98% 88.68% 89.28% 93.45%
Issuance of Preferred Stock -- -- -100.00% -100.00% -100.00%
Repurchase of Preferred Stock 51.53% -28.42% -300.71% -2,487.37% --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- 200.00%
Cash from Financing 45.29% -133.74% -723.48% -3,557.09% -423.24%
Foreign Exchange rate Adjustments 42.86% 25.00% 75.47% 111.11% 91.36%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 53.70% -96.01% -292.19% -1,386.55% -455.54%